Unlearn.AI: Unlearn Signs Multi-Year Collaboration with Merck KGaA, Darmstadt, Germany to Accelerate Immunology Trials using Twintelligent RCTs
Collaborators will leverage AI-generated Digital Twins to enable smaller, more efficient pivotal clinical trials. Unlearn, developer of the Twintelligent RCT, today announced that the company has
Charles Fisher Colin Sanford Merck Kga Merck Kgaa International Journal Of Biostatistics Biotech Breakthrough Awards Program
Source: finanznachrichten.de